| Financial Year |
March 31 2023 |
| Monetary Funds |
65,490,427.48 |
| Held-for-trading Financial Assets |
6,089,576.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
268,749,822.01 |
| Advances to Suppliers |
4,057,168.16 |
| Other Receivables |
37,576,065.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
70,273,198.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,467,101.04 |
| Total Current Assets |
480,363,728.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,784,292.55 |
| Investment Properties |
28,377,034.53 |
| Fixed Assetes |
1,032,653,690.90 |
| Under-construction Projects |
254,830,046.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,345,108.33 |
| R&D expenses |
-- |
| Goodwill |
45,394,736.80 |
| Long-Term Deferred and Prepaid Expenses |
1,693,882.79 |
| Deferred Income Tax Assets |
51,561,888.13 |
| Other Non-Current Assets |
12,071,325.00 |
| Sub-Total of Non-Current Assets |
1,646,831,534.83 |
| Total Assets |
2,127,195,263.40 |
| Short-Term Loans |
264,212,806.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,485,684.02 |
| Accounts Payable |
227,856,633.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,317,209.99 |
| Taxes Payable |
1,347,415.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,084,445.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
149,008,722.33 |
| Other Current Liabilities |
15,461.49 |
| Sub-Total of Current Liabilities |
668,338,173.15 |
| Long-term Loans |
242,703,703.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
332,086,231.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
8,199,849.81 |
| Deferred Income Tax Liabilities |
12,394,976.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
601,429,379.70 |
| Total Liabilities |
1,269,767,552.85 |
| Paid-In Capital(Or Share Stock) |
316,920,479.00 |
| Capital Surplus |
331,094,294.12 |
| Surplus Reserve |
28,462,838.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
89,851,538.74 |
| Minority Stockholder's Interest |
91,098,559.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
766,329,150.81 |
| Owner's Equity（Stockholder's Equity） |
857,427,710.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,127,195,263.40 |
